BSE filing, NSE: MODERNMAL. Summary written from the filing by ALFA Finder's alert engine.
Modern Malleables Ltd: key numbers
- Share price
- ₹46.50
- Market cap
- ₹541.8 Cr
- Revenue (annual)
- ₹150.9 Cr
- Net profit (annual)
- ₹19.32 Cr
- P/E (TTM)
- 22.2×Sector 16.9×
- Promoter holding
- 59.37%+0.00% QoQ
- FII holding
- 0.05%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Modern Malleables Ltd
All →Modern Malleables Annual General Meeting
Modern Malleables Limited concluded its 42nd Annual General Meeting on 18th September 2026. The meeting covered adoption of financial statements and routine business resolutions.
Modern Malleables Other Announcement
Modern Malleables Limited has completed the dispatch of the Notice of the 42nd AGM and Annual Report for the financial year 2025-26 to its shareholders.
Modern Malleables Annual General Meeting
Modern Malleables Ltd has scheduled its 42nd Annual General Meeting on September 18, 2026. The company will close its register of members from September 12 to 18, 2026.
Modern Malleables Board Meeting Date
Modern Malleables Limited has scheduled a Board Meeting for August 25, 2026. The meeting will focus on considering other business matters.
Modern Malleables Q1 FY27 Results: Net Profit ₹7.5 Cr, Up 212.5% YoY
Modern Malleables Ltd reported revenue from operations of ₹55.2 Cr (+98.6% YoY) and net profit of ₹7.5 Cr (+212.5% YoY) for Q1 FY27.
- Key figure
- Net profit ₹7.5 Cr · +212.5% YoY
Modern Malleables Board Meeting Date
Modern Malleables Limited has scheduled a board meeting on August 12, 2026, to consider and approve its unaudited standalone financial results for the quarter ended June 2026.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.